Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (101-110 of 332) with videos related to

Pageof 34
Sort By:
Current Pharmaceutical Design|June 21, 2016
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its ProspectiveJaved Ahmad, Sohail Akhter, Nigel H Greig, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4TracyAnn Perry, Norman J Haughey, Mark P Mattson, et al.
CNS & Neurological Disorders Drug Targets|September 25, 2013
Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatmentQurrat ul Ain, Nigel H Greig, Muhammad S Nawaz, et al.
Experimental Neurology|October 12, 2004
Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathyTracy Ann Perry, Ananda Weerasuriya, Peter R Mouton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitroChris Mahony, Lynda Erskine, Jennifer Niven, et al.
Current Alzheimer Research|June 25, 2005
Cholinesterases: roles in the brain during health and diseaseClive G Ballard, Nigel H Greig, Angela L Guillozet-Bongaarts, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Reply to D’Amato et al. and Zeldis et al.: Screening of thalidomide derivatives in chicken and zebrafish embryosNeil Vargesson, Chris Mahony, Lynda Erskine, et al.
Current Alzheimer Research|February 7, 2017
Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated OverviewKhurshid Ahmad, Mohammad Hassan Baig, Gohar Mushtaq, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Melatonin, metals, and gene expression: implications in aging and neurodegenerative disordersDebomoy K Lahiri, Demao Chen, Preeti Lahiri, et al.
The Journal of Organic Chemistry|July 30, 2005
Syntheses of tetrahydrofurobenzofurans and dihydromethanobenzodioxepines from 5-hydroxy-3-methyl-3H-benzofuran-2-one. Rearrangement and ring expansion under reductive conditions on treatment with hydridesWeiming Luo, Qian-Sheng Yu, Harold W Holloway, et al.
Pageof 34

Showing results (101-110 of 332) with videos related to

Sort By:
Pageof 34
Current Pharmaceutical Design|June 21, 2016
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its ProspectiveJaved Ahmad, Sohail Akhter, Nigel H Greig, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4TracyAnn Perry, Norman J Haughey, Mark P Mattson, et al.
CNS & Neurological Disorders Drug Targets|September 25, 2013
Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatmentQurrat ul Ain, Nigel H Greig, Muhammad S Nawaz, et al.
Experimental Neurology|October 12, 2004
Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathyTracy Ann Perry, Ananda Weerasuriya, Peter R Mouton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitroChris Mahony, Lynda Erskine, Jennifer Niven, et al.
Current Alzheimer Research|June 25, 2005
Cholinesterases: roles in the brain during health and diseaseClive G Ballard, Nigel H Greig, Angela L Guillozet-Bongaarts, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Reply to D’Amato et al. and Zeldis et al.: Screening of thalidomide derivatives in chicken and zebrafish embryosNeil Vargesson, Chris Mahony, Lynda Erskine, et al.
Current Alzheimer Research|February 7, 2017
Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated OverviewKhurshid Ahmad, Mohammad Hassan Baig, Gohar Mushtaq, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Melatonin, metals, and gene expression: implications in aging and neurodegenerative disordersDebomoy K Lahiri, Demao Chen, Preeti Lahiri, et al.
The Journal of Organic Chemistry|July 30, 2005
Syntheses of tetrahydrofurobenzofurans and dihydromethanobenzodioxepines from 5-hydroxy-3-methyl-3H-benzofuran-2-one. Rearrangement and ring expansion under reductive conditions on treatment with hydridesWeiming Luo, Qian-Sheng Yu, Harold W Holloway, et al.
Pageof 34